newsfilter
← Latest News
PR Newswire·

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership

BOSTON, July 8, 2021 /PRNewswire/ -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. This collaboration is expected to identify disease-relevant